Clinical Trials on Bacterial Infections in United States

Total 23274 results

Denver Health and Hospital Authority
United States Department of Defense; Accelerate Diagnostics, Inc.

Completed

Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections

Skin and Subcutaneous Tissue Bacterial Infections | Healthcare-associated Infection | INFECTIONS | Infection Due to Resistant Bacteria

United States
University of Michigan
Wayne State University; Henry Ford Health System; Agency for Healthcare Research... and other collaborators

Completed

Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection

Clostridium Difficile Infection | Healthcare Associated Infection | Infection Due to Multidrug Resistant Bacteria

United States
Connie Price
United States Department of Defense; Accelerate Diagnostics, Inc.

Completed

Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections (RAMPED)

Infection | Skin and Subcutaneous Tissue Bacterial Infections | Healthcare-associated Infection | Infection Due to Resistant Bacteria

United States
The Methodist Hospital Research Institute
M.D. Anderson Cancer Center; National Institute of Allergy and Infectious Diseases... and other collaborators

Recruiting

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)

Antibiotic Resistant Infection | Clostridium Difficile | Antimicrobial Drug Resistance | Carbapenem-Resistant Enterobacteriaceae Infection | Vancomycin Resistant Enterococci Infection | Vancomycin-Resistant Enterococcal Infection | Carbapenem Resistant Bacterial Infection | Extended Spectrum Beta-Lactamase...

United States
Mayo Clinic
Ortho-McNeil, Inc.

Completed

The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection

Staphylococcal Infection | Staphylococcus Aureus Prosthetic Joint Infection

United States
University of Alabama at Birmingham

Terminated

Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates

Respiratory Tract Infections | Bacteria Infection

United States
University of Maryland, Baltimore

Terminated

Targeted Gown and Glove Intervention in Nursing Homes (TAGG)

Staphylococcus Aureus | Carbapenem Resistant Gram Negative Bacteria

United States
Arpida AG

Completed

Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)

Skin Diseases, Bacterial

United States
GlaxoSmithKline

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects

Infections, Bacterial

United States
GlaxoSmithKline

Completed

To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944

Infections, Bacterial

United States
GlaxoSmithKline

Completed

A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects

Infections, Bacterial

United States
GlaxoSmithKline

Completed

Retapamulin Microdialysis Feasibility Study

Skin Infections, Bacterial

United States
Aaron Chen
Johns Hopkins University; Thrasher Research Fund

Completed

Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections

Staphylococcal Skin Infection | Abscess | Staphylococcal Infection | Folliculitis

United States
TD Vaccines A/S
Johns Hopkins University; University of Vermont; SNBL Clinical Pharmacology Center... and other collaborators

Unknown

ACE393-103 Vaccination Challenge Study (ACE393-103VC)

Campylobacter Infection

United States
GlaxoSmithKline

Completed

Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects

Infections, Bacterial

United States
GlaxoSmithKline

Terminated

A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects

Infections, Bacterial

United States
GlaxoSmithKline

Completed

Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects

Infections, Bacterial

United States
GlaxoSmithKline

Completed

Drug-drug Interaction Study of Gepotidacin

Infections, Bacterial

United States
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Completed

Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function

Infections, Bacterial

United States
GlaxoSmithKline

Completed

Relative Bioavailability Study in Healthy Subjects (PDF112034)

Infections, Bacterial

United States
Washington University School of Medicine

Completed

Individualized vs. Household MRSA Decolonization (HOME2DS)

Staphylococcal Skin Infection | Abscess | Furunculosis | Staphylococcus Aureus | MRSA Infection

United States
The Medicines Company

Completed

A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Acute Bacterial Skin and Skin Structure Infection

United States
Cumberland Pharmaceuticals

Completed

Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) (FAST)

Burns | Ulcer | Abscess | Cellulitis | Wound Infections | Infections, Gram-Positive Bacterial

United States
NYU Langone Health
National Institute on Minority Health and Health Disparities (NIMHD)

Completed

Patient-Centered Cancer Prevention In Chinese Americans

H. Pylori Infection

United States
NorthShore University HealthSystem

Terminated

FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI

Clostridium Difficile Infection

United States
GlaxoSmithKline

Completed

A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose

Infections, Bacterial

United States
Boston Medical Center

Terminated

Fecal Microbiota Transplant for Primary CDI

Clostridium Difficile Infection

United States
The Miriam Hospital

Unknown

Gut Microbiota Changes After Fecal Microbiota Transplantation

Clostridium Difficile Infection

United States
Washington University School of Medicine
Centers for Disease Control and Prevention

Withdrawn

Fidaxomicin to Prevent Clostridium Difficile Colonization

Clostridium Difficile Infection

United States
Theravance Biopharma

Completed

TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection

Staphylococcal Skin Infection

United States
Cumberland Pharmaceuticals

Completed

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus (ATLAS1)

Staphylococcal Skin Infection

United States
Mayo Clinic

Completed

The Impact of Proton Pump Inhibitors on the Fecal Microbiome

Healthy | Clostridium Difficile Infection

United States
Allergan

Completed

Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Bacterial Infections | Acute Bacterial Skin and Skin Structure Infection

United States
Northwell Health
Staten Island University Hospital

Completed

Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes?

Tuberculosis

United States
Trius Therapeutics LLC

Completed

Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg

Bacterial Infection

United States
Metro Health, Michigan

Completed

Chlorhexidine Gluconate Versus Povidone-Iodine as Vaginal Preparation Antiseptics Prior to Cesarean Delivery

Infection, Bacterial

United States
University of Pittsburgh

Completed

Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria

Bacterial Infection

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Safety of Intravenous Apramycin in Adults

Bacterial Infection

United States
Wayne State University
Forest Laboratories; Henry Ford Hospital; St. John Providence Health System; Detroit...

Completed

Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA

Skin Diseases, Infectious | Staphylococcal Skin Infections

United States
GlaxoSmithKline

Completed

To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.

Infections, Bacterial

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam

Bacterial Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)

Bacterial Infection

United States
Duke University
University of North Carolina, Chapel Hill; Durham VA Medical Center

Completed

Characterizing and Comparing the Profile of Microorganisms From Specific Body Sites and Environmental Surfaces in Newly Disinfected Patient Rooms

Bacterial Infection

United States
JHP Pharmaceuticals LLC
Syneos Health

Unknown

Equivalence Study of Specificity of PPD (03)

Tuberculosis Infection

United States
Baylor College of Medicine
Allergan

Completed

Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children

Osteomyelitis | Bone Infection | Hematogenously Acquired Staphylococcus Aureus Osteomyelitis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Human Immunity Against Staphylococcus Aureus Skin Infection

Staphylococcus Aureus Skin Infection

United States
GlaxoSmithKline

Completed

Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus

Infections, Bacterial

United States
RizLab Health, Inc.
Baylor College of Medicine

Recruiting

Micro-hematology Analyzer for Viral/Bacterial Description

Infection, Bacterial | Infection Viral

United States
JHP Pharmaceuticals LLC
Syneos Health

Unknown

Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)

Tuberculosis Infection

United States
Cumberland Pharmaceuticals

Completed

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus (ATLAS2)

Staphylococcal Skin Infection

United States

Clinical Trials on Bacterial Infections in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations